[HTML][HTML] Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
R Inchingolo, A Posa, M Mariappan… - World journal of …, 2019 - ncbi.nlm.nih.gov
Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions.
R Inchingolo, A Posa, M Mariappan… - World Journal of …, 2019 - europepmc.org
Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
R Inchingolo, A Posa, M Mariappan… - World journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
[HTML][HTML] Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
R Inchingolo, A Posa, M Mariappan… - World Journal of …, 2019 - wjgnet.com
Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
R Inchingolo, A Posa, M Mariappan… - World Journal of …, 2019 - wjgnet.com
Figure 1 Drug Eluting Beads-Trans Arterial Chemo Embolization of 3 cm hepatocellular
carcinoma. A: Gd-EOB-DTPA enhanced MR image of a 73 years old cirrhotic patient with a 3 …
carcinoma. A: Gd-EOB-DTPA enhanced MR image of a 73 years old cirrhotic patient with a 3 …